Gts Securities LLC Regeneron Pharmaceuticals, Inc. Call Options Transaction History

Gts Securities LLC

  • $54.2 Billion
  • Q1 2024

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2024

May 15, 2024
SELL
$902.69 - $993.35 $9.12 Million - $10 Million
-10,100 Reduced 43.35%
13,200 $12.7 Million
Q4 2023

Feb 14, 2024
SELL
$775.18 - $881.7 $465,107 - $529,020
-600 Reduced 2.51%
23,300 $20.5 Million
Q3 2023

Nov 15, 2023
BUY
$692.45 - $844.37 $16.5 Million - $20.2 Million
23,900 New
23,900 $19.7 Million

Others Institutions Holding REGN

# of Institutions
1,426
Shares Held
82.1M
Call Options Held
835K
Put Options Held
1.46M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $112B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Gts Securities LLC Portfolio

Follow Gts Securities LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gts Securities LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gts Securities LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email